- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00486356 | Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer | completed | Phase 1 | 46 | University of NebraskaOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT01206465 | Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors | completed | Phase 1 | 29 | University of NebraskaOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT04739293 |
| Study of ON 123300 in Patients With Advanced Cancer |
| unknown |
| Phase 1 |
| 36 |
| Traws Pharma, Inc.INDUSTRY |
| 1 |
| Dec 7, 2023 |
| clinicaltrials |
| NCT03941262 | Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy | completed | Phase 1 | 27 | NKGen Biotech, Inc.INDUSTRY | 1 | Nov 13, 2023 | clinicaltrials |
| NCT05866692 | A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors | recruiting | Phase 1 | 156 | TYK Medicines, IncINDUSTRY | 1 | Nov 7, 2023 | clinicaltrials |
| NCT04811781 | Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study | completed | — | 761 | Istituto Oncologico Veneto IRCCSOTHER | 1 | Nov 1, 2023 | clinicaltrials |
| NCT06056323 | A Study of HB0045 Injection in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 71 | Shanghai Huaota Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Oct 23, 2023 | clinicaltrials |
| NCT03274661 | Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors | completed | Phase 2 | 52 | Baptist Health South FloridaOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT03382340 | IMX-110 in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 70 | Immix Biopharma Australia Pty LtdINDUSTRY | 2 | Sep 28, 2023 | clinicaltrials |
| NCT03859752 | TR1801-ADC in Patients With Tumors That Express c-Met | suspended | Phase 1 | 15 | Open Innovation Partners, Inc.INDUSTRY | 1 | Sep 22, 2023 | clinicaltrials |
| NCT04551885 | FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors | terminated | Phase 1 | 12 | Fate TherapeuticsINDUSTRY | 1 | Sep 21, 2023 | clinicaltrials |
| NCT05069935 | FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors | terminated | Phase 1 | 16 | Fate TherapeuticsINDUSTRY | 1 | Sep 21, 2023 | clinicaltrials |
| NCT05698888 | Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors | terminated | Phase 1 | 2 | Virtuoso BINco, Inc.INDUSTRY | 1 | Sep 21, 2023 | clinicaltrials |
| NCT05284214 | Sargramostim With Ipilimumab Containing Therapy in Patients With Solid Tumors(SALIENT) | withdrawn | Phase 2 | 0 | Partner Therapeutics, Inc.INDUSTRY | 1 | Sep 15, 2023 | clinicaltrials |
| NCT05947695 | Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer | recruiting | N/A | 100 | Good Samaritan Hospital Medical Center, New YorkOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT06027346 | A Study of Bio-008 in Subjects With Advanced or Metastatic Solid Tumours | unknown | Phase 1 | 60 | Shijiazhuang Yiling Pharmaceutical Co. LtdINDUSTRY | 1 | Sep 7, 2023 | clinicaltrials |
| NCT05296772 | Phase 1 First-in-human Study of JS014 | unknown | Phase 1 | 60 | Anwita BiosciencesINDUSTRY | 1 | Sep 6, 2023 | clinicaltrials |
| NCT05631886 | Combination of CAR-DC Vaccine and ICIs in Malignant Tumors | recruiting | Phase 1 | 10 | Chinese PLA General HospitalOTHER | 1 | Aug 28, 2023 | clinicaltrials |
| NCT04467853 | A Clinical Study to Evaluate CAR-T Cell-based Medicinal Product in the Treatment of Advanced Solid Tumors | terminated | Phase 1 | 34 | Shanghai East HospitalOTHER | 1 | Aug 15, 2023 | clinicaltrials |
| NCT05986981 | MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers | unknown | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT00084734 | Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 61 | Roswell Park Cancer InstituteOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT00107250 | AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07) | completed | Phase 1 | 50 | NCIC Clinical Trials GroupNETWORK | 1 | Aug 4, 2023 | clinicaltrials |
| NCT00357747 | AEG35156 and Docetaxel in Treating Patients With Solid Tumors | completed | Phase 1 | 10 | NCIC Clinical Trials GroupNETWORK | 1 | Aug 4, 2023 | clinicaltrials |
| NCT00372736 | AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors | completed | Phase 1 | 27 | NCIC Clinical Trials GroupNETWORK | 1 | Aug 4, 2023 | clinicaltrials |
| NCT00390117 | AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma | completed | Phase 1 | 34 | NCIC Clinical Trials GroupNETWORK | 1 | Aug 4, 2023 | clinicaltrials |
| NCT00443976 | Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma | completed | Phase 1 | 35 | NCIC Clinical Trials GroupNETWORK | 1 | Aug 4, 2023 | clinicaltrials |
| NCT00471432 | OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors | completed | Phase 1 | 40 | NCIC Clinical Trials GroupNETWORK | 0 | Aug 4, 2023 | clinicaltrials |
| NCT00504296 | SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 39 | NCIC Clinical Trials GroupNETWORK | 1 | Aug 4, 2023 | clinicaltrials |
| NCT00813423 | Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Aug 2, 2023 | clinicaltrials |
| NCT05947487 | CD70 Targeted CAR-T Cells in CD70 Positive Advanced/Metastatic Solid Tumors | recruiting | Phase 1 / Phase 2 | 30 | Chinese PLA General HospitalOTHER | 1 | Jul 17, 2023 | clinicaltrials |
| NCT00091169 | Levocarnitine in Treating Fatigue in Cancer Patients | completed | Phase 3 | 376 | ECOG-ACRIN Cancer Research GroupNETWORK | 1 | Jul 5, 2023 | clinicaltrials |
| NCT00003266 | Methylphenidate in Treating Patients With Melanoma | completed | Phase 3 | 200 | Eastern Cooperative Oncology GroupNETWORK | 3 | Jun 18, 2023 | clinicaltrials |
| NCT00002520 | Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer | completed | N/A | 434 | Eastern Cooperative Oncology GroupNETWORK | 1 | Jun 15, 2023 | clinicaltrials |
| NCT05747339 | A Clinical Study on the Efficacy and Mechanism of Tumor Treatment Vaccine (TTV) for Recurrent and Refractory Advanced Solid Tumors | unknown | N/A | 50 | Wuxi People's HospitalOTHER | 0 | Jun 13, 2023 | clinicaltrials |
| NCT03892018 | The Effect of Food on the Pharmacokinetics of Paclitaxel Administered Orally as Oraxol | terminated | Phase 1 | 29 | Athenex, Inc.INDUSTRY | 1 | May 22, 2023 | clinicaltrials |
| NCT05518799 | CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours | completed | N/A | 18 | The Netherlands Cancer InstituteOTHER | 1 | May 22, 2023 | clinicaltrials |
| NCT01971489 | Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | Roswell Park Cancer InstituteOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT04650451 | Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors | suspended | Phase 1 | 220 | Bellicum PharmaceuticalsINDUSTRY | 1 | Apr 20, 2023 | clinicaltrials |
| NCT04084951 | Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 30 | SQZ BiotechnologiesINDUSTRY | 3 | Apr 14, 2023 | clinicaltrials |
| NCT02270450 | S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction | completed | N/A | 221 | SWOG Cancer Research NetworkNETWORK | 5 | Mar 30, 2023 | clinicaltrials |
| NCT04053673 | Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors | unknown | Phase 1 | 130 | Ribon Therapeutics, Inc.INDUSTRY | 2 | Mar 28, 2023 | clinicaltrials |
| NCT05759234 | A Study of HS248 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 24 | Hanhui Pharmaceutical Co., LtdINDUSTRY | 1 | Mar 8, 2023 | clinicaltrials |
| NCT03475953 | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors(REGOMUNE) | unknown | Phase 1 / Phase 2 | 747 | Institut BergoniéOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT04683354 | Study of HL-085 in Patients With Advanced Solid Tumor Tumors | completed | Phase 1 | 28 | Kechow Pharma, Inc.INDUSTRY | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05538676 | Fluoride-labeled Boronophenylalanine PET Imaging in Patients With Solid Tumors | unknown | — | 10 | Xiaohua ZhuOTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT00936728 | White Wine or Nutritional Supplement in Improving Appetite in Patients With Cancer | completed | N/A | 140 | Academic and Community Cancer Research UnitedOTHER | 1 | Feb 1, 2023 | clinicaltrials |
| NCT03789773 | Holographic Mm-Wave Imaging in Patients Undergoing Radiation Therapy | withdrawn | N/A | 0 | University of Southern CaliforniaOTHER | 1 | Feb 1, 2023 | clinicaltrials |
| NCT04252339 | RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 56 | Hoffmann-La RocheINDUSTRY | 1 | Jan 31, 2023 | clinicaltrials |
| NCT05060276 | Study to Assess an Anti-Trop2 Antibody Drug Conjugate in Relapsed or Refractory Solid Tumors | withdrawn | Phase 1 | 0 | Sorrento Therapeutics, Inc.INDUSTRY | 0 | Jan 26, 2023 | clinicaltrials |
| NCT05666635 | Study of LTC004 in Subjects With Advanced Malignant Tumors | unknown | Phase 1 | 368 | LetolabINDUSTRY | 0 | Dec 28, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Jan 3, 2024source: clinicaltrials